Jgp Global Gestao De Recursos Ltda. Amicus Therapeutics, Inc. Transaction History

Jgp Global Gestao De Recursos Ltda.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$10.96 - $14.4 $366,842 - $481,982	-33,471 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$10.04 - $13.92 $31,967 - $44,321	3,184 Added 10.51%	33,471 $455,000
Q4 2018 Jan 23, 2019	SELL	$8.38 - $13.44 $12,762 - $20,469	-1,523 Reduced 4.79%	30,287 $290,000
Q3 2018 Oct 25, 2018	BUY	$11.6 - $16.54 $152,180 - $216,988	13,119 Added 70.19%	31,810 $385,000
Q2 2018 Aug 10, 2018	SELL	$13.13 - $17.09 $250,546 - $326,111	-19,082 Reduced 50.52%	18,691 $292,000
Q1 2018 Apr 17, 2018	BUY	$13.76 - $17.12 $49,866 - $62,042	3,624 Added 10.61%	37,773 $568,000
Q4 2017 Feb 01, 2018	SELL	$12.51 - $16.24 $45,336 - $58,853	-3,624 Reduced 9.59%	34,149 $491,000
Q3 2017 Nov 09, 2017	BUY	$11.74 - $15.78 $443,455 - $596,057	37,773	37,773 $570,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.